GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Takara Bio Inc (FRA:TF2) » Definitions » E10

Takara Bio (FRA:TF2) E10 : €0.33 (As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Takara Bio E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Takara Bio's adjusted earnings per share data for the three months ended in Sep. 2024 was €0.082. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.33 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Takara Bio's average E10 Growth Rate was 1.00% per year. During the past 3 years, the average E10 Growth Rate was 32.70% per year. During the past 5 years, the average E10 Growth Rate was 38.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Takara Bio was 49.80% per year. The lowest was 27.30% per year. And the median was 38.70% per year.

As of today (2025-01-18), Takara Bio's current stock price is €5.95. Takara Bio's E10 for the quarter that ended in Sep. 2024 was €0.33. Takara Bio's Shiller PE Ratio of today is 18.03.

During the past 13 years, the highest Shiller PE Ratio of Takara Bio was 279.01. The lowest was 17.95. And the median was 117.70.


Takara Bio E10 Historical Data

The historical data trend for Takara Bio's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takara Bio E10 Chart

Takara Bio Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 0.17 0.28 0.35 0.31

Takara Bio Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 0.33 0.31 0.29 0.33

Competitive Comparison of Takara Bio's E10

For the Biotechnology subindustry, Takara Bio's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Takara Bio's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Takara Bio's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Takara Bio's Shiller PE Ratio falls into.



Takara Bio E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Takara Bio's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.082/108.9000*108.9000
=0.082

Current CPI (Sep. 2024) = 108.9000.

Takara Bio Quarterly Data

per share eps CPI Adj_EPS
201412 -0.028 97.900 -0.031
201503 0.067 97.900 0.075
201506 -0.002 98.400 -0.002
201509 0.011 98.500 0.012
201512 0.029 98.100 0.032
201603 0.048 97.900 0.053
201606 0.020 98.100 0.022
201609 0.028 98.000 0.031
201612 0.061 98.400 0.068
201703 -0.014 98.100 -0.016
201706 0.002 98.500 0.002
201709 0.018 98.800 0.020
201712 0.048 99.400 0.053
201803 0.080 99.200 0.088
201806 0.067 99.200 0.074
201809 0.044 99.900 0.048
201812 0.024 99.700 0.026
201903 0.104 99.700 0.114
201906 0.108 99.800 0.118
201909 0.034 100.100 0.037
201912 0.043 100.500 0.047
202003 0.078 100.300 0.085
202006 0.028 99.900 0.031
202009 0.125 99.900 0.136
202012 0.227 99.300 0.249
202103 0.245 99.900 0.267
202106 0.377 99.500 0.413
202109 0.255 100.100 0.277
202112 0.281 100.100 0.306
202203 0.349 101.100 0.376
202206 0.229 101.800 0.245
202209 0.271 103.100 0.286
202212 0.352 104.100 0.368
202303 0.082 104.400 0.086
202306 0.017 105.200 0.018
202309 0.040 106.200 0.041
202312 -0.049 106.800 -0.050
202403 0.068 107.200 0.069
202406 -0.051 108.200 -0.051
202409 0.082 108.900 0.082

Add all the adjusted EPS together and divide 10 will get our e10.


Takara Bio  (FRA:TF2) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Takara Bio's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=5.95/0.33
=18.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Takara Bio was 279.01. The lowest was 17.95. And the median was 117.70.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Takara Bio E10 Related Terms

Thank you for viewing the detailed overview of Takara Bio's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Takara Bio Business Description

Traded in Other Exchanges
Address
Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, JPN, 520-0058
Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.

Takara Bio Headlines

No Headlines